J A Lust - JoVE Visualize

Showing results (21-30 of 85) with videos related to

Pageof 9

Sort By:

Journal of Clinical Immunology|January 1, 1997

Gamma delta T lymphocytosis associated with common variable immunodeficiencyR K Katial, M M Lieberman, S L Muehlbauer, et al.

Electrophoresis|September 1, 1996

Evaluation of capillary electrophoresis in polymer solutions with laser-induced fluorescence detection for the automated detection of T-cell gene rearrangements in lymphoproliferative disordersR P Oda, M J Wick, L M Rueckert, et al.

Blood|December 24, 1998

Comparison of interleukin-1 beta expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myelomaM Q Lacy, K A Donovan, J K Heimbach, et al.

Cancer|August 15, 1991

Unusual presentation of extranodal peripheral T-cell lymphomas with multiple paraneoplastic featuresJ L Diez-Martin, J A Lust, T E Witzig, et al.

Medical Oncology (Northwood, London, England)|August 24, 1999

Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.

American Journal of Hematology|June 15, 1999

Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.

Blood|June 15, 1993

Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myelomaP R Greipp, J A Lust, W M O'Fallon, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999

Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.

Blood|September 1, 1996

Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myelomaT E Witzig, M A Gertz, J A Lust, et al.

Leukemia|May 1, 1996

Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6J J Westendorf, G J Ahmann, P R Greipp, et al.

Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:

Pageof 9

Journal of Clinical Immunology|January 1, 1997

Gamma delta T lymphocytosis associated with common variable immunodeficiencyR K Katial, M M Lieberman, S L Muehlbauer, et al.

Electrophoresis|September 1, 1996

Evaluation of capillary electrophoresis in polymer solutions with laser-induced fluorescence detection for the automated detection of T-cell gene rearrangements in lymphoproliferative disordersR P Oda, M J Wick, L M Rueckert, et al.

Blood|December 24, 1998

Comparison of interleukin-1 beta expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myelomaM Q Lacy, K A Donovan, J K Heimbach, et al.

Cancer|August 15, 1991

Unusual presentation of extranodal peripheral T-cell lymphomas with multiple paraneoplastic featuresJ L Diez-Martin, J A Lust, T E Witzig, et al.

Medical Oncology (Northwood, London, England)|August 24, 1999

Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.

American Journal of Hematology|June 15, 1999

Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.

Blood|June 15, 1993

Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myelomaP R Greipp, J A Lust, W M O'Fallon, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999

Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.

Blood|September 1, 1996

Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myelomaT E Witzig, M A Gertz, J A Lust, et al.

Leukemia|May 1, 1996

Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6J J Westendorf, G J Ahmann, P R Greipp, et al.

Pageof 9